Genentech Flu Drug Scores Another Late-Stage Win
With flu season fast approaching, Genentech has some good news for people who are at high risk of complications from the illness.
The Home of the Life Sciences Industry
Explore Latest News
Roivant Launches New China-Based Startup Sinovant Sciences
Fresh off its first Pipeline Day last week, Vivek Ramaswamy’s Roivant Sciences is taking aim at breaking into the Chinese market. Roivant has launched another company called Sinovant Sciences.
- China’s Ascentage Pharma Snags $150 Million to Support Pipeline Development
- New Study Says DNA Damage From CRISPR-Cas9 Gene-Editing Has Been Underestimated
- Ramaswamy’s Urovant, Four Other Companies, Join IPO Frenzy
- June was a Busy Month for the FDA, Which Approved 7 Novel Drug Approvals
- With Looming Bioterrorism Threats, FDA Approves First Smallpox Therapeutic
Employers
Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.